transplant Flashcards
most important HLA for recipient/donor matching?
HLA-DR.
type IV hypersensitivity
what does cross match entail? reagents.
recipient serum with donor lymphocytes.
to r/o hyperacute rejection.= type II hypersensitivity
1 and 2 malignancy after transplant
squamous skin ca ? PTLD (EBV)
mycophenalate mofetil MOA?
inhibit de novo purine synthesis to stop T CELL GROWTH.
cyclosporin MOA?
binds cyclophilin to inhibit calcineurin to decrease cytokine synth.
metabolism: LIVER.
tacrolimus MOA?
like cyclosporin but more potent. via FKBP.
metabolism: less LIVER>
sirolimus MOA?
binds FKBP like tac but inhibits mammalian target of rapamycin (mTOR) to decrease T and B cell response to IL-2.
LESS* NEPHROTOX* compared to tac or cyclosporin.
sirolimus side effect?
interstitial lung dz.
antithymocyte globulin MOA?
polyclonal Abs against T cell antigens CD2,3,4.
types of rejection?
hyperacute, accelerated, acute cellular, acute humeral, chronic.
hyperacute rejection?
min-hrs = preformed Abs Type II (I.e. ABO)
tx: re-transplant
accelerated rejection?
<1 wk = sensitized T cells to donor HLA
tx: increase Rx, steroids
acute cellular rejection?
after 1 wk.
T cells to HLA Ag
tx: immunosuppresion
acute humeral rejection?
after 1 wk.
Abs to donor Ags
tx: steroids, Ab therapy, plasmapharesis.
chronic rejection?
mos-years.
Abs formed and T cells sensitized… partially type IV
MC: HLA incompatibility
tx: immunosuppresion, retxp
new proteinuria after kidney txp?
renal vein thrombosis.
pathology of acute rejection in kidney txp?
1-6 mos…
Bx: tubulitis (vasculitis with more severe form)
5 yr kidney graft survival?
70%.
65 cad, 75 liv
MC cause of death after kidney transplant?
MI
how long extended survival after kidney transplant?
15 years.